VIOO - ETF AI Analysis
Top Page
Vanguard S&P Small-Cap 600 ETF (VIOO)
VIOO, the Vanguard S&P Small-Cap 600 ETF, has a solid overall rating driven mainly by several strong small-cap holdings with healthy growth and strategic progress, such as Paycom, which shows robust revenue, profitability, and a positive outlook, and Jackson Financial, which combines strong earnings with reasonable valuation. At the same time, some holdings like ViaSat and Glaukos face profitability and leverage or valuation challenges, and a few names show bearish or cautious technical trends, which slightly weigh on the fund’s rating and highlight the risk that comes from exposure to smaller, more volatile companies.
VIOO vs. SPDR S&P 500 ETF (SPY)
- AUM
- 4.14B
- Region
- North America
- Expense Ratio
- 0.07%
- Beta
- 0.92
- Issuer
- Vanguard
- Inception Date
- Sep 07, 2010
- Dividend Yield
- 1.14%
- Asset Class
- Equity
- Index Tracked
- S&P Small Cap 600
VIOO Summary
Vanguard S&P Small-Cap 600 ETF (VIOO) is a fund that follows the S&P Small Cap 600 index, which includes 600 smaller U.S. companies across many industries like financials, technology, and health care. These are businesses that are still growing, such as Match Group and Paycom, and can offer more room for expansion than large, established firms. Investors might consider VIOO to add diversification and long-term growth potential to their portfolio through a broad mix of small U.S. companies. However, small-cap stocks can be more volatile, so the value of this ETF can go up and down more sharply than funds focused on larger companies.
How much will it cost me?
This ETF has an expense ratio of 0.07%, which means you’ll pay about $0.70 per year for every $1,000 invested. That’s lower than average because it’s a passively managed fund that simply tracks the S&P SmallCap 600 Index instead of paying managers to pick individual stocks.
What would affect this ETF?
Because VIOO focuses on U.S. small-cap stocks across sectors like financials, industrials, and technology, it can benefit from a strong U.S. economy, rising business investment, and innovation in areas such as software, semiconductors, and health care. On the downside, small caps are often hit harder by economic slowdowns, higher interest rates, and tighter credit, and company-specific setbacks in top holdings like tech, biotech, or online consumer businesses could add extra volatility.
VIOO Top 10 Holdings
VIOO is a broad U.S. small-cap fund, but its story right now is driven by a handful of nimble growth names. Health care and biotech are giving it a lift, with Glaukos and Protagonist Therapeutics rising on strong sales and promising pipelines. Tech is another key engine: Paycom and ViaSat are climbing, reflecting solid growth and upbeat outlooks, while Qorvo adds semiconductor flavor with more mixed fundamentals. On the flip side, FormFactor has been lagging lately, showing that not every chip-related name is firing. Overall, performance is powered by U.S. small-cap growth, with a tilt toward tech and health care innovation.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 FORM | Formfactor | 0.68% | $41.31M | $6.84B | 58.87% | 68Neutral |
 VSAT | ViaSat | 0.56% | $34.33M | $10.61B | 86.11% | 56Neutral |
 GKOS | Glaukos | 0.56% | $34.30M | $14.07B | 170.93% | 61Neutral |
 QRVO | Qorvo | 0.54% | $33.27M | ― | ― | 71Outperform |
 MTCH | Match Group | 0.53% | $32.63M | $9.51B | 30.09% | 66Neutral |
 PTGX | Protagonist Therapeutics | 0.53% | $32.29M | $9.37B | 77.27% | 68Neutral |
 PAYC | Paycom | 0.49% | $29.70M | $11.70B | 42.20% | 76Outperform |
 ESI | Element Solutions | 0.48% | $29.43M | $8.31B | 27.77% | 65Neutral |
 RHP | Ryman | 0.47% | $28.89M | $9.09B | 55.22% | 66Neutral |
 JXN | Jackson Financial Incorporation | 0.47% | $28.53M | $9.14B | 36.53% | 73Outperform |
VIOO Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VIOO, the sentiment is Positive. The current price of 131.70 is above the 20-day moving average (MA) of 128.62, above the 50-day MA of 130.23, and above the 200-day MA of 127.06, indicating a bullish trend. The MACD of 0.36 indicates Negative momentum. The RSI at 59.75 is Neutral, neither overbought nor oversold. The STOCH value of 82.28 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VIOO.
VIOO Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| VIOO | $131.70 | $138.00(4.78% Upside) | $4.14B | 0.07% | 66Neutral |
 IJR | $141.48 | $169.86(20.06% Upside) | $105.63B | 0.06% | 65Neutral |
 SPSM | $54.98 | $66.14(20.29% Upside) | $16.01B | 0.03% | 66Neutral |
 FNDA | $36.36 | $43.28(19.03% Upside) | $8.91B | 0.25% | 68Neutral |
 FESM | $45.48 | $59.37(30.55% Upside) | $6.76B | 0.28% | 64Neutral |
 SMLF | $85.54 | $107.07(25.17% Upside) | $4.21B | 0.15% | 66Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| VIOO | Vanguard S&P Small-Cap 600 ETF | 131.70 | 22.89 | 21.04% | |
| IJR | iShares Core S&P Small Cap ETF | 141.48 | 24.44 | 20.88% | |
| SPSM | SPDR Portfolio S&P 600 Small Cap ETF | 54.98 | 9.50 | 20.89% | |
| FNDA | Schwab Fundamental US Small Co. Index ETF | 36.36 | 6.02 | 19.83% | |
| FESM | Fidelity Enhanced Small Cap ETF | 45.48 | 8.86 | 24.21% | |
| SMLF | iShares MSCI USA Small-Cap Multifactor ETF | 85.54 | 12.03 | 16.37% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.